Queensland Centre for Medical Genomics in Australia Chooses LIMS for Next-Generation Sequencing Sample Tracking
News Nov 16, 2010
The next generation sequencing instruments at QCMG are generating terabytes of data on a weekly basis and sample tracking is quickly becoming unmanageable with existing Google docs, spreadsheets and other manual methods.
Dr Peter Wilson, executive officer at the Queensland Centre for Medical Genomics, stated, “We knew exactly what we needed when we decided to look for a commercial LIMS solution for our sequencing centre. We contacted GenoLogics because it has a proven LIMS system that can handle our needs today and will adapt to meet future requirements. Efficiently managing and tracking sample data in our lab is critical to the success of our research. We need to know where our samples are at every step of the workflow and our team needs to be able to access the history of the sample at any stage; the Geneus system provides these capabilities.”
Queensland’s high-profile sequencing centre turned to GenoLogics a few months ago, looking for a powerful LIMS solution that would enable researchers to manage and track their samples and metadata in a single centralized system. The GenoLogics solution, Geneus, provides unparalleled sample traceability and system flexibility. These capabilities were the primary considerations in the Queensland lab’s decision-making criteria. Queensland Centre for Medical Genomics will make use of the powerful and comprehensive sample genealogy view provided by Geneus that allows everyone in the lab to see (and interrogate) the history of a sample from sample submission to analysis and result reporting.
Change is constant in next-gen sequencing labs, so facilities such as the Queensland Centre for Medical Genomics need a flexible configurable LIMS that will enable users to make changes quickly without any programming delays; Geneus offers this capability.
The flagship project at The Queensland Centre for Medical Genomics (QCMG) is the sequencing of 500 pancreatic and ovarian cancer genomes as part of the International Cancer Genome Consortium (ICGC). Australia’s commitment to the ICGC has required the formation of a worldclass sequencing centre within the Institute for Molecular Bioscience (IMB), The University of Queensland (UQ). The Australian contingent of the ICGC initiative is based at the QCMG/IMB and will study the underlying changes that result in the development of pancreatic and ovarian cancer. The pancreatic cancer genome project includes significant contributions from research centers across the globe including the Ontario Institute for Cancer Research, Johns Hopkins University, the University of California, and the University of Verona.
Sysmex Partners with Laboratories to Deliver Improved QC ManagementNews
Sysmex America has announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes.READ MORE
BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-OncologyNews
QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018